In this continuation of our myeloma series, we discuss the progression of MGUS & smoldering myeloma to multiple myeloma. We also outline how to risk stratify a patient with multiple myeloma and gauge their response to treatment.
Content:
-What is the natural progression from MGUS to smoldering myeloma to multiple myeloma?
- How do we risk stratify patients with a new myeloma diagnosis?
- What is the role of FISH/karyotype in risk stratification in myeloma?
-How do we gauge disease response in myeloma?
- How do we define disease progression?
- How do we define treatment response?
- What is the role of minimal residual disease (MRD) in myeloma?
Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes
This episode has been sponsored by Primum. To sign up for a free account, check out: tfoc.primum.co
Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!
Twitter: @TheFellowOnCall
Instagram: @TheFellowOnCall
Listen in on: Apple Podcast, Spotify, and Google Podcast
